# Invesco CurrencyShares Australian Dollar Trust: overview

FXA · NYSE · CIK 1353614 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxa.md) · [Financials](/companies/fxa/financials.md) · [Filings](/companies/fxa/filings.md) · [Insiders](/companies/fxa/insiders.md)

Latest reported revenue: [$491.2k](/filings/0001193125-26-338710.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338710).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [344](/filings/0001193125-25-270327.md) | [311 d](/filings/0001193125-26-083544.md) | [288](/filings/0001193125-26-209739.md) | [330](/filings/0001193125-26-338710.md) | [306](/filings/0001193125-25-270327.md) | [260 d](/filings/0001193125-26-083544.md) | [360](/filings/0001193125-26-209739.md) | [491](/filings/0001193125-26-338710.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [79.5%](/filings/0001193125-25-270327.md) | [79.5% d](/filings/0001193125-26-083544.md) | [78.4%](/filings/0001193125-26-209739.md) | [75.6%](/filings/0001193125-26-338710.md) | [72.3%](/filings/0001193125-25-270327.md) | [70.1% d](/filings/0001193125-26-083544.md) | [73.4%](/filings/0001193125-26-209739.md) | [78.6%](/filings/0001193125-26-338710.md) |
| Diluted EPS | $ per share | [0.26](/filings/0001193125-25-270327.md) | not reported | [0.22](/filings/0001193125-26-209739.md) | [0.20](/filings/0001193125-26-338710.md) | [0.17](/filings/0001193125-25-270327.md) | not reported | [0.19](/filings/0001193125-26-209739.md) | [0.26](/filings/0001193125-26-338710.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001564590-23-002359.md) | [187](/filings/0000950170-24-019069.md) | [1,087](/filings/0000950170-25-027258.md) | [1,357](/filings/0001193125-26-083544.md) | [1,184](/filings/0001193125-26-083544.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [(96.1%)](/filings/0000950170-24-019069.md) | [73.3%](/filings/0000950170-25-027258.md) | [79.5%](/filings/0001193125-26-083544.md) | [74.2%](/filings/0001193125-26-083544.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001564590-23-002359.md) | [(0.14)](/filings/0000950170-24-019069.md) | [0.72](/filings/0000950170-25-027258.md) | [1.02](/filings/0001193125-26-083544.md) | [0.74](/filings/0001193125-26-083544.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fxa/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $8.5m | 124,394 |  | Added +2,599 |
| [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $8.1m | 117,758 |  | Added +9,094 |
| [Ashton Thomas Private Wealth, LLC](/funds/2019663.md) | 2026-06-30 | $2.5m | 36,764 |  | Unchanged |
| [FIG FINANCIAL ADVISORY SERVICES INC /ADV](/funds/753967.md) | 2026-06-30 | $1.5m | 21,973 |  | Not compared |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.5m | 21,800 | Put | New +21,800 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.3m | 18,610 |  | Reduced −979 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $905.2k | 13,200 | Put | Added +8,900 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $898.4k | 13,100 | Call | Reduced −400 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $862.6k | 12,579 |  | Added +60 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $605.0k | 8,823 |  | Reduced −430 |

## Recent filings

[All 171 filings](/companies/fxa/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 20:05 ET | [8-K](/filings/0001193125-26-427821.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-427821 |
| 2026-08-07 | 23:26 ET | [10-Q](/filings/0001193125-26-338710.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338710 |
| 2026-08-03 | 20:07 ET | [8-K](/filings/0001193125-26-330559.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-330559 |
| 2026-06-05 | 21:29 ET | [8-K](/filings/0001193125-26-259977.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-259977 |
| 2026-05-07 | 23:53 ET | [10-Q](/filings/0001193125-26-209739.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209739 |
| 2026-03-02 | 23:44 ET | [10-K](/filings/0001193125-26-083544.md) | Annual report, period 2025-12-31 | 0001193125-26-083544 |
| 2025-11-07 | 00:06 ET | [10-Q](/filings/0001193125-25-270327.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270327 |
| 2025-08-07 | 20:54 ET | [10-Q](/filings/0000950170-25-105204.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105204 |
| 2025-05-08 | 21:16 ET | [10-Q](/filings/0000950170-25-067222.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067222 |
| 2025-02-26 | 02:32 ET | [10-K](/filings/0000950170-25-027258.md) | Annual report, period 2024-12-31 | 0000950170-25-027258 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-083544.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f3155ae5-aad1-4a37-b563-b55bc030ede0)

## About the filer

- CIK: 1353614
- Tickers: FXA
- Exchange: NYSE
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: NY
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.
